A Study of the Safety and Efficacy of 4 Doses of BI 1744 CL Delivered Via the Respimat in Patients With Asthma.
Clinical trial NCT01013753 · COMPLETED
Trial details
- NCT number
- NCT01013753
- Sponsor
- Boehringer Ingelheim
- Status
- COMPLETED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2010-02-01
- Primary completion
- 2011-01-01
- Enrollment
- 198
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.